Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Salani R, Billingsley CC, Crafton SM. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol. 2014;211(1):7–14.
Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020;70(6):443–59.
AYA cancer fertility preservation guidance working group. Fertility preservation for AYAs diagnosed with cancer: guidance for health professionals. Sydney: Cancer Council Australia; 2014.
Eshre Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, Braat D, D'Angelo A, Chuva de Sousa Lopes SM, et al. ESHRE guideline: female fertility preservation. Hum Reprod Open. 2020;2020(4):hoaa052.
Oktay K, Harvey BE, Loren AW. Fertility preservation in patients with cancer: ASCO clinical practice guideline update summary. J Oncol Pract. 2018;14(6):381–5.
Paluch-Shimon S, Cardoso F, Partridge AH, Abulkhair O, Azim HA Jr, Bianchi-Micheli G, et al. ESO-ESMO 4th international consensus guidelines for breast cancer in young women (BCY4). Ann Oncol. 2020;31(6):674–96.
Lambertini M, Peccatori FA, Demeestere I, Amant F, Wyns C, Stukenborg JB, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2020;31(12):1664–78.
Pragout D, Laurence V, Baffet H, Raccah-Tebeka B, Rousset-Jablonski C. Contraception and cancer: CNGOF contraception guidelines. Gynecol Obstet Fertil Senol. 2018;46(12):834–44.
Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013;14(9):873–81.
Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006;98(13):890–6.
Green DM, Whitton JA, Stovall M, Mertens AC, Donaldson SS, Ruymann FB, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol. 2002;187(4):1070–80.
Winther JF, Boice JD Jr, Svendsen AL, Frederiksen K, Olsen JH. Induced abortions in Danish cancer survivors: a population-based cohort study. J Natl Cancer Inst. 2009;101(9):687–9.
Guth U, Huang DJ, Bitzer J, Tirri BF, Moffat R. Contraception counseling for young breast cancer patients: a practical needs assessment and a survey among medical oncologists. Breast. 2016;30:217–21.
Folsom SM, Woodruff TK. Good news on the active management of pregnant cancer patients. F1000Res. 2020;9:487
Marino JL, Saunders CM, Hickey M. Sexual inactivity in partnered female cancer survivors. Maturitas. 2017;105:89–94.
Rottmann N, Larsen PV, Johansen C, Hagedoorn M, Dalton SO, Hansen DG. Sexual activity in couples dealing with breast cancer. A cohort study of associations with patient, partner and relationship-related factors. Front Psychol. 2022:13.
Dominick SA, McLean MR, Whitcomb BW, Gorman JR, Mersereau JE, Bouknight JM, et al. Contraceptive practices among female cancer survivors of reproductive age. Obstet Gynecol. 2015;126(3):498–507.
Serfaty D. Update on the contraceptive contraindications. J Gynecol Obstet Hum Reprod. 2019;48(5):297–307.
Huber D, Seitz S, Kast K, Emons G, Ortmann O. Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review. Arch Gynecol Obstet. 2020;301(4):875–84.
Moorman PG, Havrilesky LJ, Gierisch JM, Coeytaux RR, Lowery WJ, Peragallo Urrutia R, et al. Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol. 2013;31(33):4188–98.
Faculty of Sexual and Reproductive Healthcare. UK medical eligibility criteria for contraceptive use: UKMEC; 2016.
Hadnott TN, Stark SS, Medica A, Dietz AC, Martinez ME, Whitcomb BW, et al. Perceived infertility and contraceptive use in the female, reproductive-age cancer survivor. Fertil Steril. 2019;111(4):763–71.
Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, et al. US medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65(3):1–103.
Abelman SH, Cron J. Contraception counseling and use among adolescent and young adult female patients undergoing cancer treatment: a retrospective analysis. J Pediatr Adolesc Gynecol. 2020;33(6):652–7.
Mody SK, Gorman JR, Oakley LP, Layton T, Parker BA, Panelli D. Contraceptive utilization and counseling among breast cancer survivors. J Cancer Surviv. 2019;13(3):438–46.
Lindsay SF, Woodhams EJ, White KO, Drainoni ML, Johnson NL, Yinusa-Nyahkoon L. Understanding barriers to contraception screening and referral in female adolescents and young adults with cancer. J Adolesc Young Adult Oncol. 2020;9(1):63–71.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Higgins JP, Deeks JJ. Selecting studies and collecting data. In: Cochrane handbook for systematic reviews of interventions: Cochrane book series; 2008. p. 151–85.
World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP) Knowledge for Health Project. Family planning: a global handbook for providers (2018 update). Baltimore and Geneva: CCP and WHO; 2018.
Sundaram A, Vaughan B, Kost K, Bankole A, Finer L, Singh S, et al. Contraceptive failure in the United States: estimates from the 2006-2010 National Survey of Family Growth. Perspect Sex Reprod Health. 2017;49(1):7–16.
Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147–53.
Patel A, Sreedevi M, Malapati R, Sutaria R, Schoenhage MB, Patel AR, et al. Reproductive health assessment for women with cancer: a pilot study. Am J Obstet Gynecol. 2009;201(2):191 e1–4.
Massarotti C, Lo Monaco L, Scaruffi P, Sozzi F, Remorgida V, Cagnacci A, et al. Contraception in cancer survivors: insights from oncofertility follow-up visits. Gynecol Endocrinol. 2021;37(2):166–70.
Castro-Sanchez A, Martinez-Cannon BA, Platas A, Mohar A, Fonseca A, Vega Y, et al. Suboptimal use of effective contraceptive methods in young Mexican women with breast cancer. J Glob Oncol. 2018;4:1–7.
Cutler K, Creinin M, Balagtas JM, Hou M. Rate of abnormal vaginal bleeding and contraception counseling in women undergoing chemotherapy. J Community Support Oncol. 2016;14(8):337–41.
Franca T, Barison G, Barbieri M, Torloni M, Petrilli A, Guazzelli C. Sexual life and contraceptive use among Brazilian teenage girls with cancer: preliminary results. Int J Gynaecol Obstet. 2015;131:E386.
Guth U, Huang DJ, Bitzer J, Moffat R. Unintended pregnancy during the first year after breast cancer diagnosis. Eur J Contracept Reprod Health Care. 2016;21(4):290–4.
Johansen SL, Lerma K, Shaw KA. Contraceptive counseling in reproductive-aged women treated for breast cancer at a tertiary care institution: a retrospective analysis. Contraception. 2017;96(4):248–53.
Knight S, Ogburn JA, Sokkary N. Contraception and fertility preservation counseling in reproductive-aged women diagnosed with nongynecologic cancer. Contraception. 2014;90(3):343.
Lakhdissi A, Berrada N, Bellahammou K, Akkar O, Mustapha EK, Akla S, et al. A prospective study on contraceptives used by reproductive-aged patients with breast cancer and the assessment of information. J Clin Oncol. 2017;35(5 Supplement 1).
Madrigal JM, Atluri M, Radeke EK, Patel A. Looking through the lens of a family planner to prioritize reproductive health among women with cancer. J Oncol Pract. 2019;15(2):e141–e52.
Maslow BS, Morse CB, Schanne A, Loren A, Domchek SM, Gracia CR. Contraceptive use and the role of contraceptive counseling in reproductive-aged women with cancer. Contraception. 2014;90(1):79–85.
McLean MR, Dominick SA, Whitcomb B, Su HI, Bouknight JM. Emergency contraception use and unintended pregnancy in young cancer survivors: a first study. Fertil Steril. 2014;102(3):e14.
Patel A, Roston A, Uy A, Radeke E, Roston A, Keith L, et al. Reproductive health and endocrine disruption in women with breast cancer: a pilot study. Support Care Cancer. 2015;23(2):411–8.
Quinn MM, Letourneau JM, Rosen MP. Contraception after cancer treatment: describing methods, counseling, and unintended pregnancy risk. Contraception. 2014;89(5):466–71.
Rosenberg SM, Dutton CR, Ligibel J, Barry W, Ruddy KJ, Sprunck-Harrild K, et al. Contraception use in young women with breast cancer. Cancer Research Conference: 38th Annual CTRC AACR San Antonio Breast Cancer Symposium. San Antonio, United States Conference Publication: 2016;76(4 SUPPL. 1).
Harries J, Constant D, Cairncross L, Moodley J. Contraceptive needs and fertility intentions of women with breast cancer in Cape Town, South Africa: a qualitative study. BMC Womens Health. 2020;20(1):224.
Karaoz B, Aksu H, Kucuk M. A qualitative study of the information needs of premenopausal women with breast cancer in terms of contraception, sexuality, early menopause, and fertility. Int J Gynaecol Obstet. 2010;109(2):118–20.
Birru Talabi M, Clowse MEB, Schwarz EB, Callegari LS, Moreland L, Borrero S. Family planning counseling for women with rheumatic diseases. Arthritis Care Res. 2018;70(2):169–74.
Harris ML, Egan N, Forder PM, Bateson D, Sverdlov AL, Murphy VE, et al. Patterns of contraceptive use among young Australian women with chronic disease: findings from a prospective cohort study. Reprod Health. 2022;19(1):111.
York SL, Gosiengfiao Y, Lockart B, Giordano SB, Smith K, Kiley J. Contraceptive recommendations for young women during cancer treatment: examining contraceptive knowledge of pediatric oncology clinicians. J Clin Oncol Confer. 2014;32(15 SUPPL. 1).
Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ. 2007;334(7586):194.
van Dorp W, Haupt R, Anderson RA, Mulder RL, van den Heuvel-Eibrink MM, van Dulmen-den BE, et al. Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review. J Clin Oncol. 2018;36(21):2169–80.
Ngu SF, Ngan HY. Chemotherapy in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016;33:86–101.
Reulen RC, Zeegers MP, Wallace WH, Frobisher C, Taylor AJ, Lancashire ER, et al. Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study. Cancer Epidemiol Biomark Prev. 2009;18(8):2239–47.
Mueller BA, Chow EJ, Kamineni A, Daling JR, Fraser A, Wiggins CL, et al. Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis. Arch Pediatr Adolesc Med. 2009;163(10):879–86.
Hines MR, Mulrooney DA, Hudson MM, Ness KK, Green DM, Howard SC, et al. Pregnancy-associated cardiomyopathy in survivors of childhood cancer. J Cancer Surviv. 2016;10(1):113–21.
Johansen S, Lerma K, Henry S, Tamaresis J, Wood D, Shaw K. Contraceptive counseling for reproductive-aged women treated at Stanford Cancer Institute: a retrospective analysis. Contraception. 2016;94(4):413.
Harris ML, Egan N, Forder PM, Bateson D, Loxton D. Patterns of contraceptive use through later reproductive years: a prospective cohort study of Australian women with chronic disease. medRxiv. 2022; Preprint.
Harris ML, Egan N, Forder PM, Coombe J, Loxton D. Contraceptive use among women through their later reproductive years: findings from an Australian prospective cohort study. PLoS One. 2021;16(8):e0255913.
Frederiksen LE, Ernst A, Brix N, Braskhoj Lauridsen LL, Roos L, Ramlau-Hansen CH, et al. Risk of adverse pregnancy outcomes at advanced maternal age. Obstet Gynecol. 2018;131(3):457–63.
Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit. Contraception for women aged over 40 years. UK: FSRH; 2017.
Goldhammer DL, Fraser C, Wigginton B, Harris ML, Bateson D, Loxton D, et al. What do young Australian women want (when talking to doctors about contraception)? BMC Fam Pract. 2017;18(1):35.
Harris ML, Coombe J, Forder PM, Lucke JC, Bateson D, Loxton D. Young women’s complex patterns of contraceptive use: findings from an Australian cohort study. Perspect Sex Reprod Health. 2020;52(3):181–90.
Coombe J, Harris ML, Loxton D. What qualities of long-acting reversible contraception do women perceive as desirable or undesirable? A systematic review. Sex Health. 2016.
Gilleland Marchak J, Elchuri SV, Vangile K, Wasilewski-Masker K, Mertens AC, Meacham LR. Perceptions of infertility risks among female pediatric cancer survivors following gonadotoxic therapy. J Pediatr Hematol Oncol. 2015;37(5):368–72.
Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer. 2010;116(4):791–8.
Wigginton B, Harris ML, Loxton D, Lucke JC. A qualitative analysis of women’s explanations for changing contraception: the importance of non-contraceptive effects. J Fam Plann Reprod Health Care. 2016;42(4):256–62.